CompletedPhase 2NCT00221546

Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Ghent
Principal Investigator
Armand Christophe, MD, PhD
University Hospital, Ghent
Intervention
Giving DHA-rich supplement(drug)
Enrollment
17 enrolled
Eligibility
6 years · All sexes
Timeline
20072008

Study locations (1)

Collaborators

Belgian Society against Cystic Fibrosis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00221546 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials